Из книги P. Marino, The ICU book, 3rd edition
Don't Use Low-Dose Dopamine
Despite more than thirty years of use as a renal vasodilator, low-dose dopamine (2 μg/kg/min) has shown no evidence of benefit in patients with acute oliguric renal failure (10,11). In fact, low-dose dopamine can have deleterious effects on hemodynamics (decreased splanchnic blood flow), immune function (inhibition of T-cell lymphocyte function) and endocrine function (inhibition of thyroid-stimulating hormone release from the pituitary) (11). For these reasons, the use of low-dose dopamine in patients with acute oliguria is (borrowing the title from reference 11) bad medicine.
10. Kellum JA, Decker JM. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med 2001;29:1526–1531.
11. Holmes CL, Walley KR. Bad medicine: low-dose dopamine in the ICU. Chest 2003;123:1266–1275.